EZR and breast cancer: Since resistin consequentially increases ezrin phosphorylation, and ezrin knock-down blocks resistin-induced breast cancer cell invasion [87], PP2A-mediated ezrin phosphorylation may be a critical regulator of breast cancer metastasis.